当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析

海正药业

(600267)

  

流通市值:127.49亿  总市值:127.56亿
流通股本:11.98亿   总股本:11.99亿

海正药业(600267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.05亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益858998.42万元,未分配利润259176.09万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1556357.23万元,负债697358.81万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入5,250,334,553.432,631,818,241.6710,340,247,008.477,874,540,640.41
营业总成本4,675,003,997.92,362,401,236.889,570,389,705.327,323,584,992.31
其他经营收益
营业利润419,458,928.05250,471,888.13721,334,031.14606,424,781.72
利润总额404,300,181.64249,385,681.21718,072,071.49605,520,255.63
净利润304,913,629.54196,797,891.73591,311,870.59510,285,014.19
每股收益
其他综合收益-605,808.91-324,622.95952,422.72-512,365.67
综合收益总额304,307,820.63196,473,268.78592,264,293.31509,772,648.52
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,720,125,510.995,897,305,458.335,661,385,005.935,784,199,658.54
非流动资产:
非流动资产合计9,843,446,835.4510,110,449,382.6510,311,093,062.0710,472,796,739.84
资产总计15,563,572,346.4416,007,754,840.9815,972,478,06816,256,996,398.38
流动负债:
流动负债合计6,265,456,365.276,079,301,038.316,137,895,871.766,247,289,721.31
非流动负债:
非流动负债合计708,131,734.731,151,870,754.961,255,568,760.821,514,151,094.37
负债合计6,973,588,1007,231,171,793.277,393,464,632.587,761,440,815.68
所有者权益(或股东权益):
归属于母公司股东权益合计8,346,480,929.488,536,352,053.628,341,353,163.168,253,047,844.7
股东权益合计8,589,984,246.448,776,583,047.718,579,013,435.428,495,555,582.7
负债和股东权益合计15,563,572,346.4416,007,754,840.9815,972,478,06816,256,996,398.38
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计6,108,834,393.822,843,620,352.0611,513,932,334.718,762,648,025.7
经营活动现金流出小计4,897,799,984.152,580,913,287.079,329,838,798.167,307,068,164.93
经营活动产生的现金流量净额1,211,034,409.67262,707,064.992,184,093,536.551,455,579,860.77
投资活动产生的现金流量:
投资活动现金流入小计18,371,045.144,573,625.94450,390,902.2638,549,327.58
投资活动现金流出小计145,642,794.2774,910,902.88740,751,821.2158,848,779.83
投资活动产生的现金流量净额-127,271,749.13-70,337,276.94-290,360,918.94-120,299,452.25
筹资活动产生的现金流量:
筹资活动现金流入小计1,195,029,200.48569,343,2304,392,067,7963,452,000,000
筹资活动现金流出小计1,887,822,002.74642,410,691.696,429,012,989.724,926,235,217.19
筹资活动产生的现金流量净额-692,792,802.26-73,067,461.69-2,036,945,193.72-1,474,235,217.19
汇率变动对现金及现金等价物的影响677,653.7559,053.483,474,327.912,597,714.07
现金及现金等价物净增加额391,647,512.03119,361,379.83-139,738,248.2-136,357,094.6
期末现金及现金等价物余额1,581,531,918.731,309,245,786.531,189,884,406.711,193,265,560.31
补充资料:
现金及现金等价物的净增加额391,647,512.03--139,738,248.21-
TOP↑